NASDAQ:TNXP | Free Cash Flow | Tonix Pharmaceuticals Holding Corp.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$42.32M$1.69M-$44.01M
2025-12-31-$39.65M$1.87M-$41.52M
2025-03-31-$16.58M$6,000.00-$16.59M
2024-12-31-$14.63M$3,000.00-$14.63M
2024-03-31-$17.58M$108,000.00-$17.68M
2023-12-31-$22.34M$438,000.00-$22.78M
2023-03-31-$32.91M$3.8M-$36.71M
2022-12-31-$22.3M$4.67M-$26.97M
2022-03-31-$31.05M$20.22M-$51.26M
2021-12-31-$22.45M$25.62M-$48.07M
2021-03-31-$21.06M$505,000.00-$21.56M
2020-12-31-$13.91M$4.53M-$18.45M
2020-03-31-$9.33M
2019-12-31-$6.68M$5,000.00-$6.69M
2019-03-31-$8.64M$7,000.00-$8.65M
2018-12-31-$6.82M-$1,000.00-$6.83M
2018-03-31-$6.77M$2,000.00-$6.77M
2017-12-31-$4.93M$3,000.00-$4.93M
2017-03-31-$4.79M
2016-12-31-$5.44M$0.00-$5.44M
2016-03-31-$15.49M$65,000.00-$15.55M
2015-12-31-$11.91M$50,000.00-$11.96M
2015-03-31-$9.05M$0.00-$9.05M
2014-12-31-$8.22M$125,000.00-$8.34M
2014-03-31-$4.06M$2,000.00-$4.07M
2013-12-31-$3.53M$7,000.00-$3.54M
2013-03-31-$1.36M$0.00-$1.36M
2012-12-31-$1.51M$327.00-$1.51M
2012-03-31-$1.78M$0.00-$1.78M
2011-12-31-$1.47M$0.00-$1.47M
2011-03-31-$380,949.00$2,764.00-$383,713.00
2010-12-31-$1.22M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$99.84M$3.37M-$103.21M
2024-12-31-$60.93M$120,000.00-$61.05M
2023-12-31-$102M$7.9M-$109.9M
2022-12-31-$98.05M$48.15M-$146.2M
2021-12-31-$75.56M$35.31M-$110.86M
2020-12-31-$48.57M$8.56M-$57.13M
2019-12-31-$26.68M$17,000.00-$26.7M
2018-12-31-$23.97M$6,000.00-$23.98M
2017-12-31-$19.13M$5,000.00-$19.13M
2016-12-31-$37.31M$66,000.00-$37.38M
2015-12-31-$42.53M$118,000.00-$42.65M
2014-12-31-$22.84M$319,000.00-$23.16M
2013-12-31-$8.52M$15,000.00-$8.53M
2012-12-31-$5.71M$36,000.00-$5.75M
2011-12-31-$2.64M$2,764.00-$2.64M
2010-12-31-$1.23M$34,279.00-$1.27M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.